Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000095.xml
Z Geburtshilfe Neonatol 2024; 228(01): 42-48
DOI: 10.1055/a-2220-7469
DOI: 10.1055/a-2220-7469
Review
An Update on COVID-19-Associated Placental Pathologies
Ein Update zu COVID-19-assoziierten Pathologien in der Plazenta
Abstract
COVID-19 pregnancies are associated with increased rates of premature delivery and stillbirths. It is still a matter of debate whether there is a COVID-19-associated pattern of placenta pathology. We updated our previously published results on a systematic literature review and meta-analysis of COVID-19 pregnancies. In total, 38 reports on 3677 placentas were evaluated regarding histopathological changes. Maternal vascular malperfusion (32%), fetal vascular malperfusion (19%), acute and chronic inflammation (20% and 22%) were frequent pathologies. In non-COVID-19 pregnancies, placentas show similar histologic patterns and mainly similar frequencies of manifestation. It has to be taken into account that there might be an observation bias, because some findings are diagnosed as a “pathology” that might have been classified as minor or unspecific findings in non-COVID-19 placentas. COVID-19 placentitis occurs in 1–2% of cases at the most. In conclusion, this updated meta-analysis indicates that COVID-19 infection during pregnancy does not result in an increased rate of a specific placenta pathology and COVID-19 placentitis is rare.
Publication History
Received: 31 July 2023
Accepted after revision: 21 November 2023
Article published online:
08 February 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Marchand G, Patil AS, Masoud AT. et al. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021. AJOG Glob Rep 2022; 2: 100049 DOI: 10.1016/j.xagr.2021.100049.
- 2 Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res 2023; 251: 84-95 DOI: 10.1016/j.trsl.2022.08.007.
- 3 Giuliani F, Oros D, Gunier RB. et al. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study. Am J Obstet Gynecol 2022; 227: 488.e1-488.e17 DOI: 10.1016/j.ajog.2022.04.019.
- 4 Mullins E, Perry A, Banerjee J. et al. Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study. Eur J Obstet Gynecol Reprod Biol 2022; 276: 161-167 DOI: 10.1016/j.ejogrb.2022.07.010.
- 5 Smith ER, Oakley E, Grandner GW. et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol 2023; 228: 161-177 DOI: 10.1016/j.ajog.2022.08.038.
- 6 Epelboin S, Labrosse J, De Mouzon J. et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study. PLoS Med 2021; 18: e1003857 DOI: 10.1371/journal.pmed.1003857.
- 7 McClymont E, Albert AY, Alton GD. et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA 2022; 327: 1983-1991 DOI: 10.1001/jama.2022.5906.
- 8 Eskenazi B, Rauch S, Iurlaro E. et al. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study. Am J Obstet Gynecol 2022; 227: 74 e71-74 e16 DOI: 10.1016/j.ajog.2021.12.032.
- 9 Mihajlovic S, Nikolic D, Milicic B. et al. Association of pre-pregnancy obesity and COVID-19 with poor pregnancy outcome. J Clin Med 2023; 12: 2936 DOI: 10.3390/jcm12082936.
- 10 Vivanti AJ, Vauloup-Fellous C, Escourrou G. et al. Factors associated with SARS-CoV-2 transplacental transmission. Am J Obstet Gynecol 2022; 227: 541-543 e511 DOI: 10.1016/j.ajog.2022.05.015.
- 11 Sukhikh G, Petrova U, Prikhodko A. et al. Vertical transmission of SARS-CoV-2 in second trimester associated with severe neonatal pathology. Viruses 2021; 13: 447 DOI: 10.3390/v13030447.
- 12 Pulinx B, Kieffer D, Michiels I. et al. Vertical transmission of SARS-CoV-2 infection and preterm birth. Eur J Clin Microbiol Infect Dis 2020; 39: 2441-2445 DOI: 10.1007/s10096-020-03964-y.
- 13 Alamar I, Abu-Arja MH, Heyman T. et al. A possible case of vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a newborn with positive placental in situ hybridization of SARS-CoV-2 RNA. J Pediatric Infect Dis Soc 2020; 9: 636-639 DOI: 10.1093/jpids/piaa109.
- 14 Schwartz DA, Baldewijns M, Benachi A. et al. Chronic histiocytic intervillositis with trophoblast necrosis is a risk factor associated with placental infection from coronavirus disease 2019 (COVID-19) and intrauterine maternal-fetal severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) transmission in live-born and stillborn infants. Arch Pathol Lab Med 2021; 145: 517-528 DOI: 10.5858/arpa.2020-0771-SA.
- 15 Zaigham M, Gisselsson D, Sand A. et al. Clinical-pathological features in placentas of pregnancies with SARS-CoV-2 infection and adverse outcome: case series with and without congenital transmission. BJOG 2022; 129: 1361-1374 DOI: 10.1111/1471-0528.17132.
- 16 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71 DOI: 10.1136/bmj.n71.
- 17 Suhren JT, Meinardus A, Hussein K. et al. Meta-analysis on COVID-19-pregnancy-related placental pathologies shows no specific pattern. Placenta 2022; 117: 72-77 DOI: 10.1016/j.placenta.2021.10.010.
- 18 Khong TY, Mooney EE, Ariel I. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med 2016; 140: 698-713 DOI: 10.5858/arpa.2015-0225-CC.
- 19 Zhang P, Heyman T, Greechan M. et al. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers. J Matern Fetal Neonatal Med 2022; 35: 5783-5791 DOI: 10.1080/14767058.2021.1892637.
- 20 Baergen RN, Heller DS. Placental pathology in Covid-19 positive mothers: Preliminary findings. Pediatr Dev Pathol 2020; 23: 177-180 DOI: 10.1177/1093526620925569.
- 21 Levitan D, London V, McLaren RA. et al. Histologic and Immunohistochemical evaluation of 65 placentas from women with polymerase chain reaction-proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Arch Pathol Lab Med 2021; 145: 648-656 DOI: 10.5858/arpa.2020-0793-SA.
- 22 Blasco Santana L, Miraval Wong E, Alvarez-Troncoso J. et al. Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation. J Obstet Gynaecol Res 2021; 47: 2131-2139 DOI: 10.1111/jog.14784.
- 23 Hecht JL, Quade B, Deshpande V. et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod Pathol 2020; 33: 2092-2103 DOI: 10.1038/s41379-020-0639-4.
- 24 Edlow AG, Li JZ, Collier AY. et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020; 3: e2030455 DOI: 10.1001/jamanetworkopen.2020.30455.
- 25 Debelenko L, Katsyv I, Chong AM. et al. Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2. Hum Pathol 2021; 109: 69-79 DOI: 10.1016/j.humpath.2020.12.004.
- 26 Glynn SM, Yang YJ, Thomas C. et al. SARS-CoV-2 and placental pathology: Malperfusion patterns are dependent on timing of infection during pregnancy. Am J Surg Pathol 2022; 46: 51-57 DOI: 10.1097/PAS.0000000000001772.
- 27 Arcos Junior GF, Francisco RPV, Kill B. et al. Placental pathological findings in coronavirus disease 2019: Perinatal outcomes. Placenta 2022; 128: 23-28 DOI: 10.1016/j.placenta.2022.08.006.
- 28 Jani S, Jacques SM, Qureshi F. et al. Clinical characteristics of mother-infant dyad and placental pathology in COVID-19 cases in predominantly African American population. AJP Rep 2021; 11: e15-e20 DOI: 10.1055/s-0040-1721673.
- 29 Tasca C, Rossi RS, Corti S. et al. Placental pathology in COVID-19 affected pregnant women: A prospective case-control study. Placenta 2021; 110: 9-15 DOI: 10.1016/j.placenta.2021.04.002.
- 30 Lu-Culligan A, Chavan AR, Vijayakumar P. et al. SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface. medRxiv 2021; DOI: 10.1101/2021.01.25.21250452.
- 31 Resta L, Vimercati A, Cazzato G. et al. SARS-CoV-2 and Placenta: New Insights and Perspectives. Viruses 2021; 13 DOI: 10.3390/v13050723.
- 32 Husen MF, van der Meeren LE, Verdijk RM. et al. Unique severe COVID-19 placental signature independent of severity of clinical maternal symptoms. Viruses 2021; 13: 1670 DOI: 10.3390/v13081670.
- 33 Nunes MC, Jones S, Strehlau R. et al. Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women. J Glob Health 2022; 12: 05050 DOI: 10.7189/jogh.12.05050.
- 34 Pomorski M, Trzeszcz M, Matera-Witkiewicz A. et al. SARS-CoV-2 infection and pregnancy: Maternal and neonatal outcomes and placental pathology correlations. Viruses 2022; 14: 2043 DOI: 10.3390/v14092043.
- 35 Celik E, Vatansever C, Ozcan G. et al. Placental deficiency during maternal SARS-CoV-2 infection. Placenta 2022; 117: 47-56 DOI: 10.1016/j.placenta.2021.10.012.
- 36 Montans Araujo J, Suy Franch A, Garcia Ruiz I. et al. Impact of COVID-19 disease on placental histopathology. PLAXAVID study. Histol Histopathol 2023; 18639 DOI: 10.14670/HH-18-639.
- 37 Garg R, Agarwal R, Yadav D. et al. Histopathological changes in placenta of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and maternal and perinatal outcome in COVID-19. J Obstet Gynaecol India 2023; 73: 44-50 DOI: 10.1007/s13224-022-01666-3.
- 38 Arora D, Rajmohan KS, Singh S. et al. Correlation between placental histopathology and perinatal outcome in COVID-19. Tzu Chi Med J 2022; 34: 329-336 DOI: 10.4103/tcmj.tcmj_233_21.
- 39 Ward JD, Cornaby C, Kato T. et al. The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies. Placenta 2022; 123: 12-23 DOI: 10.1016/j.placenta.2022.04.006.
- 40 Boyraz B, James K, Hornick JL. et al. Placental pathology from COVID-19-recovered (nonacute) patients. Hum Pathol 2022; 125: 18-22 DOI: 10.1016/j.humpath.2022.04.005.
- 41 Joshi B, Chandi A, Srinivasan R. et al. The placental pathology in Coronavirus disease 2019 infected mothers and its impact on pregnancy outcome. Placenta 2022; 127: 1-7 DOI: 10.1016/j.placenta.2022.07.009.
- 42 Milot C, Koch A, Averous G. et al. Development of placental lesions after recovery from COVID-19 during pregnancy: case-control study. BJOG 2023; 130: 949-958 DOI: 10.1111/1471-0528.17458.
- 43 Salvatore MA, Corsi Decenti E, Bonasoni MP. et al. Placental characteristics of a large italian cohort of SARS-CoV-2-positive pregnant women. Microorganisms 2022; 10: 1435 DOI: 10.3390/microorganisms10071435.
- 44 Carbonnel M, Daclin C, Tourne M. et al. Impact of COVID-19 on subclinical placental thrombosis and maternal thrombotic factors. J Clin Med 2022; 11: 4067 DOI: 10.3390/jcm11144067.
- 45 Brien ME, Bernier E, Clavel J. et al. Mediators of inflammation at the maternal-fetal interface are altered by SARS-CoV-2 infection and pandemic stress. Am J Reprod Immunol 2023; 89: e13679 DOI: 10.1111/aji.13679.
- 46 Dagelic A, Stefanovic V, Resic Karara J. et al. Does COVID-19 infection acquired in different pregnancy trimester influence placental pathology?. J Perinat Med 2023; 51: 607-613 DOI: 10.1515/jpm-2022-0452.
- 47 Corbetta-Rastelli CM, Altendahl M, Gasper C. et al. Analysis of placental pathology after COVID-19 by timing and severity of infection. Am J Obstet Gynecol MFM 2023; 5: 100981 DOI: 10.1016/j.ajogmf.2023.100981.
- 48 Dubucs C, Groussolles M, Ousselin J. et al. Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death. Hum Pathol 2022; 121: 46-55 DOI: 10.1016/j.humpath.2021.12.012.
- 49 Hernandez PV, Chen L, Zhang R. et al. The effects of preconception and early gestation SARS-CoV-2 infection on pregnancy outcomes and placental pathology. Ann Diagn Pathol 2023; 62: 152076 DOI: 10.1016/j.anndiagpath.2022.152076.
- 50 Wong YP, Tan GC, Omar SZ. et al. SARS-CoV-2 infection in pregnancy: Placental histomorphological patterns, disease severity and perinatal outcomes. Int J Environ Res Public Health 2022; 19: 9517 DOI: 10.3390/ijerph19159517.
- 51 Redline RW, Ravishankar S, Bagby C. et al. Diffuse and localized SARS-CoV-2 placentitis: Prevalence and pathogenesis of an uncommon complication of COVID-19 infection during pregnancy. Am J Surg Pathol 2022; 46: 1036-1047 DOI: 10.1097/PAS.0000000000001889.
- 52 Argueta LB, Lacko LA, Bram Y. et al. SARS-CoV-2 infects syncytiotrophoblast and activates inflammatory responses in the placenta. bioRxiv 2021; DOI: 10.1101/2021.06.01.446676.
- 53 Colley CS, Hutchinson JC, Whitten SM. et al. Routine placental histopathology findings from women testing positive for SARS-CoV-2 during pregnancy: Retrospective cohort comparative study. BJOG 2023; 130: 959-967 DOI: 10.1111/1471-0528.17476.
- 54 Damman E, Trecourt A, de la Fourniere B. et al. Predictive factors for severe placental damage in pregnant women with SARS-CoV-2 infection. Placenta 2023; 136: 1-7 DOI: 10.1016/j.placenta.2023.03.004.
- 55 Sarno L, Locci M, Fulgione C. et al. Characteristics of placental histopathology in women with uncomplicated pregnancies affected by SARS-CoV-2 infection at the time of delivery: A single-center experience. Biomedicines 2022; 10: 3003 DOI: 10.3390/biomedicines10123003.
- 56 Cribiu FM, Erra R, Pugni L. et al. Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission. J Clin Invest 2021; 131 DOI: 10.1172/JCI145427.
- 57 Schwartz DA, Baldewijns M, Benachi A. et al. Hofbauer cells and COVID-19 in pregnancy. Arch Pathol Lab Med 2021; 145: 1328-1340 DOI: 10.5858/arpa.2021-0296-SA.
- 58 Taglauer E, Benarroch Y, Rop K. et al. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta 2020; 100: 69-74 DOI: 10.1016/j.placenta.2020.08.015.
- 59 Roberts DJ, Edlow AG, Romero RJ. et al. A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop. Am J Obstet Gynecol 2021; 225: 593 e591-593 e599 DOI: 10.1016/j.ajog.2021.07.029.
- 60 Cornish EF, McDonnell T, Williams DJ. Chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome. Front Immunol 2022; 13: 825075 DOI: 10.3389/fimmu.2022.825075.
- 61 Heeralall C, Ibrahim UH, Lazarus L. et al. The effects of COVID-19 on placental morphology. Placenta 2023; 138: 88-96 DOI: 10.1016/j.placenta.2023.05.009.
- 62 Papageorghiou AT, Deruelle P, Gunier RB. et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol 2021; 225: 289 e281-289 e217 DOI: 10.1016/j.ajog.2021.05.014.
- 63 Villar J, Ariff S, Gunier RB. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175: 817-826 DOI: 10.1001/jamapediatrics.2021.1050.
- 64 Ackermann M, Verleden SE, Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-128 DOI: 10.1056/NEJMoa2015432.
- 65 Funai EF, Labowsky AT, Drewes CE. et al. Timing of fetal meconium absorption by amnionic macrophages. Am J Perinatol 2009; 26: 93-97 DOI: 10.1055/s-0028-1103028.
- 66 Conti N, Torricelli M, Voltolini C. et al. Term histologic chorioamnionitis: a heterogeneous condition. Eur J Obstet Gynecol Reprod Biol 2015; 188: 34-38 DOI: 10.1016/j.ejogrb.2015.02.034.
- 67 Linehan L, O’Donoghue K, Dineen S. et al. SARS-CoV-2 placentitis: An uncommon complication of maternal COVID-19. Placenta 2021; 104: 261-266 DOI: 10.1016/j.placenta.2021.01.012.
- 68 Fitzgerald B, O’Donoghue K, McEntagart N. et al. Fetal deaths in Ireland due to SARS-CoV-2 placentitis caused by SARS-CoV-2 Alpha. Arch Pathol Lab Med 2022; 146: 529-537 DOI: 10.5858/arpa.2021-0586-SA.
- 69 Watkins JC, Torous VF, Roberts DJ. Defining severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) placentitis. Arch Pathol Lab Med 2021; 145: 1341-1349 DOI: 10.5858/arpa.2021-0246-SA.
- 70 Shook LL, Brigida S, Regan J. et al. SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise. J Infect Dis 2022; 225: 754-758 DOI: 10.1093/infdis/jiac008.
- 71 Kato M, Yamaguchi K, Maegawa Y. et al. Intrauterine fetal death during COVID-19 pregnancy: Typical fetal heart rate changes, coagulopathy, and placentitis. J Obstet Gynaecol Res 2022; 48: 1978-1982 DOI: 10.1111/jog.15302.
- 72 Hussein K, Stucki-Koch A, Kreipe H. et al. Expression of toll-like receptors in chronic histiocytic intervillositis of the placenta. Fetal Pediatr Pathol 2015; 34: 407-412 DOI: 10.3109/15513815.2015.1095259.
- 73 Feist H, Lehmann U, Bajwa S. et al. Villitis of unknown etiology, chronic deciduitis, chronic chorioamnionitis and chronic histiocytic intervillositis in monozygotic and dizygotic twin pregnancies. A retrospective analysis of 16 cases. Placenta 2023; 133: 32-39 DOI: 10.1016/j.placenta.2023.02.002.